VIDEO: Study shows ivarmacitinib safe, efficacious in treating moderate-to-severe AD

Jeremy Visser
Jul 2
1 min read

According to a recent study, ivarmacitinib, a Januse kinase (JAK)-1 inhibitor, has been shown to be effective and safe in treating adolescent and adult patients with atopic dermatitis (AD).

Recent Posts

See All

VIDEO: Biologic therapy linked to increased risk of superficial fungal infection in PsO patients

Biologic treatment of psoriasis can raise the risk of superficial fungal infections in patients, especially with IL-17 inhibitors.

VIDEO: Oral nutraceutical may improve skin health, acne in adult women

VIDEO: AI model may assist clinicians with skin cancer diagnoses

it's where dermatology lives

VIDEO: Study shows ivarmacitinib safe, efficacious in treating moderate-to-severe AD

Recent Posts

Comments